Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (71-80 of 508) with videos related to

Pageof 51
Sort By:
Therapeutic Advances in Endocrinology and Metabolism|June 4, 2020
Hypoglycaemia and cardiac arrhythmias in diabetesAndreas Andersen, Peter G Jørgensen, Filip K Knop, et al.
The Review of Diabetic Studies : RDS|January 21, 2012
Therapy for obesity based on gastrointestinal hormonesJonatan I Bagger, Mikkel Christensen, Filip K Knop, et al.
The Review of Diabetic Studies : RDS|January 21, 2012
The alpha-cell as target for type 2 diabetes therapyMikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, et al.
Diabetes, Obesity & Metabolism|February 23, 2021
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weightSimone Theilade, Mikkel B Christensen, Tina Vilsbøll, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 27, 2002
[What is the cost of vascular operations? A prospective cost analysis of conventional and combined endovascular interventions]G Lang, K Knop, R Pamler, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 14, 2015
Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacyAndreas Brønden, Signe V Naver, Filip K Knop, et al.
Acta Ophthalmologica|July 7, 2015
Retinal vascular and structural dynamics during acute hyperglycaemiaOliver N Klefter, Tina Vilsbøll, Filip K Knop, et al.
Diseases of the Colon and Rectum|December 29, 2004
Delayed ischemic cecal perforation despite optimal decompression after placement of a self-expanding metal stent: report of a caseFilip K Knop, Bo Pilsgaard, Søren Meisner, et al.
Idrugs : the Investigational Drugs Journal|July 25, 2009
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Jens J Holst, et al.
Expert Opinion on Drug Safety|January 20, 2017
Cardiovascular safety and benefits of GLP-1 receptor agonistsNiels B Dalsgaard, Andreas Brønden, Tina Vilsbøll, et al.
Pageof 51

Showing results (71-80 of 508) with videos related to

Sort By:
Pageof 51
Therapeutic Advances in Endocrinology and Metabolism|June 4, 2020
Hypoglycaemia and cardiac arrhythmias in diabetesAndreas Andersen, Peter G Jørgensen, Filip K Knop, et al.
The Review of Diabetic Studies : RDS|January 21, 2012
Therapy for obesity based on gastrointestinal hormonesJonatan I Bagger, Mikkel Christensen, Filip K Knop, et al.
The Review of Diabetic Studies : RDS|January 21, 2012
The alpha-cell as target for type 2 diabetes therapyMikkel Christensen, Jonatan I Bagger, Tina Vilsbøll, et al.
Diabetes, Obesity & Metabolism|February 23, 2021
An overview of obesity mechanisms in humans: Endocrine regulation of food intake, eating behaviour and common determinants of body weightSimone Theilade, Mikkel B Christensen, Tina Vilsbøll, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|April 27, 2002
[What is the cost of vascular operations? A prospective cost analysis of conventional and combined endovascular interventions]G Lang, K Knop, R Pamler, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 14, 2015
Albiglutide for treating type 2 diabetes: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacyAndreas Brønden, Signe V Naver, Filip K Knop, et al.
Acta Ophthalmologica|July 7, 2015
Retinal vascular and structural dynamics during acute hyperglycaemiaOliver N Klefter, Tina Vilsbøll, Filip K Knop, et al.
Diseases of the Colon and Rectum|December 29, 2004
Delayed ischemic cecal perforation despite optimal decompression after placement of a self-expanding metal stent: report of a caseFilip K Knop, Bo Pilsgaard, Søren Meisner, et al.
Idrugs : the Investigational Drugs Journal|July 25, 2009
Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Jens J Holst, et al.
Expert Opinion on Drug Safety|January 20, 2017
Cardiovascular safety and benefits of GLP-1 receptor agonistsNiels B Dalsgaard, Andreas Brønden, Tina Vilsbøll, et al.
Pageof 51